Andres Quesada - Concepedia

Author

Andres Quesada

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A E Quesada, A Quesada, A. Quesada, Andres E. Quesada, Andres E Quesada, Andres E. Quesada, Andres Ernesto Quesada, Andres Quesada, Andrés E Quesada, Andrés E. Quesada

121

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Memorial Sloan Kettering Cancer Center University of Washington University of Arkansas for Medical Sciences

About

Andres Quesada is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	658
2	Health Sciences	5	5	237
3	Cell Biology	4	4	107
4	Engineering	2	2	61
5	Gastroenterology	1	1	34

Andres Quesada

Publications

936

Citations

H-Index

Page 1

	Year	Citations
<i>DDX41</i> mutations in myeloid neoplasms are associated with male gender, <i>TP53</i> mutations and high‐risk disease Andres Quesada, Mark J. Routbort, Courtney D. DiNardo, American Journal of Hematology Hematological MalignancyOncologyCancer PathologyMyeloid NeoplasmsSomatic Variant	2019	104
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma María C. Ferrufino‐Schmidt, L. Jeffrey Medeiros, Hui Liu, The American Journal of Surgical Pathology Surgical OncologyBreast OncologyLymph Node InvolvementPathologyOncology	2017	94
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma Andres Quesada, L. Jeffrey Medeiros, Parth Desai, Modern Pathology Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineHematology	2017	53
Characteristics and clinical outcomes of patients with myeloid malignancies and <scp><i>DDX41</i></scp> variants Álex Bataller, Sanam Loghavi, Yoheved Gerstein, American Journal of Hematology Mixed-phenotype Acute LeukemiaMyeloid MalignanciesPathologyDdx41 VariantsMyeloid Neoplasia	2023	41
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations Hatice Gur, Sanam Loghavi, Guillermo Garcia‐Manero, The American Journal of Surgical Pathology Chronic Myelomonocytic LeukemiaEngineeringCmml PatientsMixed-phenotype Acute LeukemiaImmunology	2018	40
Prognostic significance of cytogenetic abnormalities in T‐cell prolymphocytic leukemia Zhihong Hu, L. Jeffrey Medeiros, Lianghua Fang, American Journal of Hematology CytogeneticsGenetics≥5 AberrationsPathologyPrognostic Significance	2017	39
Myeloid/lymphoid neoplasms with FLT3 rearrangement Guilin Tang, Wayne Tam, Nicholas J. Short, Modern Pathology Lymphoid NeoplasiaFlt3 RearrangementMedicineMalignant Blood DisorderPathology	2021	39
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma Kirill A. Lyapichev, Sergio Piña‐Oviedo, L. Jeffrey Medeiros, Modern Pathology Lymphoid NeoplasiaBreast OncologyHealth SciencesBreast Implant CapsulesBreast Cancer	2019	37
The absolute percent deviation of <i><scp>IGHV</scp></i> mutation rather than a 98% cut‐off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab Preetesh Jain, Graciela M. Nogueras‐González, Rashmi Kanagal‐Shamanna, British Journal of Haematology	2017	36
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing Andres Quesada, Zhihong Hu, Mark J. Routbort, Oncotarget	2018	35

Page 1